Viewing Study NCT01996332


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-01-24 @ 11:43 PM
Study NCT ID: NCT01996332
Status: COMPLETED
Last Update Posted: 2014-07-10
First Post: 2013-11-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords: